Revenue
$249.72M
Fiscal year ended 2026-06-30Operating income
$22.48M
Fiscal year ended 2026-06-30Free cash flow
$52.87M
Fiscal year ended 2026-06-30MESA LABORATORIES INC /CO/ (MLAB) reported revenue of $249.72M and net income of $4.80M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from MESA LABORATORIES INC /CO/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Industrial Instruments For Measurement, Display, and Control.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $249.72M |
| Cost of revenue | $89.38M |
| Gross profit | $160.34M |
| Operating income | $22.48M |
| Net income | $4.80M |
| Research & development | $20.05M |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $9.36M |
| Income tax expense | $4.56M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | Unavailable |
| General & administrative | $78.08M |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | $30.70M |
| Total assets | $419.22M |
| Current assets | $102.85M |
| Total liabilities | $230.46M |
| Current liabilities | $57.32M |
| Total equity incl. NCI | $188.76M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $27.23M |
| Accounts receivable | $34.41M |
| Goodwill | $186.04M |
| Long-term debt | $66.09M |
| Accounts payable | $7.46M |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $55.67M |
| Capital expenditures | $2.80M |
| Investing cash flow | -$2.80M |
| Financing cash flow | -$43.92M |
| Net change in cash | $9.42M |
| Stock-based compensation | $16.35M |
| Common dividends paid | $3.53M |
| Common share repurchases | Unavailable |
| Depreciation & amortization | Unavailable |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | $52.87M |
| Gross margin | 64.2% |
| Operating margin | 9.0% |
| FCF margin | 21.2% |
| SBC / revenue | 6.5% |
| Current ratio | 1.79x |
| Revenue YoY growth | 3.0% |
| Net margin | 1.9% |
| R&D / revenue | 8.0% |
| CapEx / revenue | 1.1% |
| Long-term debt / equity | 0.35x |
| Effective tax rate | 48.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MLAB in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-K · Filed 2026-06-03View SEC filing
10-Q · Filed 2026-02-03View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-K · Filed 2025-05-28View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.